HealthLynked Statistics
Total Valuation
HealthLynked has a market cap or net worth of 12.09 million. The enterprise value is 17.86 million.
| Market Cap | 12.09M |
| Enterprise Value | 17.86M |
Important Dates
The next estimated earnings date is Friday, March 6, 2026.
| Earnings Date | Mar 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthLynked has 2.88 million shares outstanding. The number of shares has increased by 1.41% in one year.
| Current Share Class | 2.88M |
| Shares Outstanding | 2.88M |
| Shares Change (YoY) | +1.41% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 31.31% |
| Owned by Institutions (%) | 0.00% |
| Float | 1.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.09 |
| PB Ratio | -2.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.66 |
| EV / Sales | 7.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.23
| Current Ratio | 0.23 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -64.43% |
| Return on Invested Capital (ROIC) | -167.25% |
| Return on Capital Employed (ROCE) | 46.81% |
| Weighted Average Cost of Capital (WACC) | 17.08% |
| Revenue Per Employee | 118,702 |
| Profits Per Employee | -191,699 |
| Employee Count | 20 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 24.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +80.35% in the last 52 weeks. The beta is 2.02, so HealthLynked's price volatility has been higher than the market average.
| Beta (5Y) | 2.02 |
| 52-Week Price Change | +80.35% |
| 50-Day Moving Average | 2.05 |
| 200-Day Moving Average | 2.34 |
| Relative Strength Index (RSI) | 91.22 |
| Average Volume (20 Days) | 4,597 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.20 |
Income Statement
In the last 12 months, HealthLynked had revenue of 2.37 million and -3.83 million in losses. Loss per share was -1.36.
| Revenue | 2.37M |
| Gross Profit | 1.00M |
| Operating Income | -2.33M |
| Pretax Income | -3.83M |
| Net Income | -3.83M |
| EBITDA | -2.23M |
| EBIT | -2.33M |
| Loss Per Share | -1.36 |
Balance Sheet
The company has 10,911 in cash and 5.78 million in debt, with a net cash position of -5.77 million or -2.00 per share.
| Cash & Cash Equivalents | 10,911 |
| Total Debt | 5.78M |
| Net Cash | -5.77M |
| Net Cash Per Share | -2.00 |
| Equity (Book Value) | -5.43M |
| Book Value Per Share | -1.91 |
| Working Capital | -5.20M |
Cash Flow
| Operating Cash Flow | -2.04M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 42.32%, with operating and profit margins of -98.19% and -161.50%.
| Gross Margin | 42.32% |
| Operating Margin | -98.19% |
| Pretax Margin | -161.50% |
| Profit Margin | -161.50% |
| EBITDA Margin | -93.82% |
| EBIT Margin | -98.19% |
| FCF Margin | n/a |
Dividends & Yields
HealthLynked does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.41% |
| Shareholder Yield | -1.41% |
| Earnings Yield | -31.71% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 4, 2025. It was a reverse split with a ratio of 0.01.
| Last Split Date | Sep 4, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
HealthLynked has an Altman Z-Score of -46.08 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -46.08 |
| Piotroski F-Score | 4 |